| Mr Edward J Kata Jr, MD | |
|
2400 N Orange Blossom Trl Ste 102, Kissimmee, FL 34744-2307 | |
| (407) 944-4947 | |
| (407) 874-7802 |
| Full Name | Mr Edward J Kata Jr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 36 Years |
| Location | 2400 N Orange Blossom Trl Ste 102, Kissimmee, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467497586 | NPI | - | NPPES |
| 340013139 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME66751 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Medical Group Inc | 0749186153 | 1163 |
News Archive
Emergent BioSolutions Inc. announced today that its investigational anthrax vaccine, NuThrax, has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA).
Zyngenia, Inc., a privately held biotherapeutics company focused on next-generation antibody drug development, announced today the completion of a $15 million Series A financing extension from New Enterprise Associates (NEA), one of the world's leading venture capital firms. The capital will be used to continue to rapidly progress Zyngenia's pipeline of Zybodies™, which are novel, multi-specific, antibody-based molecules that address two or more biological targets with a single protein drug.
Children and teens who are abused, witness violence, are bullied or face other adversities are more likely to develop cardiovascular diseases in adulthood, according to a new scientific statement by the American Heart Association published in the Association's journal Circulation.
Despite the prevalence of the painful condition, women are fearful and frustrated with limited management options, according to Cedars-Sinai research published in the Journal of Urology.
The U.S. Department of Veterans Affairs should expand the requirement in its disability compensation process regarding who can diagnose traumatic brain injury to include any health care professional with pertinent and ongoing brain injury training and experience, says a new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine.
› Verified 6 days ago
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
Emergent BioSolutions Inc. announced today that its investigational anthrax vaccine, NuThrax, has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA).
Zyngenia, Inc., a privately held biotherapeutics company focused on next-generation antibody drug development, announced today the completion of a $15 million Series A financing extension from New Enterprise Associates (NEA), one of the world's leading venture capital firms. The capital will be used to continue to rapidly progress Zyngenia's pipeline of Zybodies™, which are novel, multi-specific, antibody-based molecules that address two or more biological targets with a single protein drug.
Children and teens who are abused, witness violence, are bullied or face other adversities are more likely to develop cardiovascular diseases in adulthood, according to a new scientific statement by the American Heart Association published in the Association's journal Circulation.
Despite the prevalence of the painful condition, women are fearful and frustrated with limited management options, according to Cedars-Sinai research published in the Journal of Urology.
The U.S. Department of Veterans Affairs should expand the requirement in its disability compensation process regarding who can diagnose traumatic brain injury to include any health care professional with pertinent and ongoing brain injury training and experience, says a new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Edward J Kata Jr, MD 2400 N Orange Blossom Trl Ste 102, Kissimmee, FL 34744-2307 Ph: (407) 944-4947 | Mr Edward J Kata Jr, MD 2400 N Orange Blossom Trl Ste 102, Kissimmee, FL 34744-2307 Ph: (407) 944-4947 |
News Archive
Emergent BioSolutions Inc. announced today that its investigational anthrax vaccine, NuThrax, has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA).
Zyngenia, Inc., a privately held biotherapeutics company focused on next-generation antibody drug development, announced today the completion of a $15 million Series A financing extension from New Enterprise Associates (NEA), one of the world's leading venture capital firms. The capital will be used to continue to rapidly progress Zyngenia's pipeline of Zybodies™, which are novel, multi-specific, antibody-based molecules that address two or more biological targets with a single protein drug.
Children and teens who are abused, witness violence, are bullied or face other adversities are more likely to develop cardiovascular diseases in adulthood, according to a new scientific statement by the American Heart Association published in the Association's journal Circulation.
Despite the prevalence of the painful condition, women are fearful and frustrated with limited management options, according to Cedars-Sinai research published in the Journal of Urology.
The U.S. Department of Veterans Affairs should expand the requirement in its disability compensation process regarding who can diagnose traumatic brain injury to include any health care professional with pertinent and ongoing brain injury training and experience, says a new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine.
› Verified 6 days ago
Dr. Sarat C Sabharwal, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1056 E Osceola Pkwy, Kissimmee, FL 34744 Phone: 407-808-5656 Fax: 407-809-5554 | |
Dr. David A Melendez, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 591 Oak Commons Blvd, Kissimmee, FL 34741 Phone: 407-943-7100 Fax: 407-943-7328 | |
Zaid Atir Fadhli, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2400 N Orange Blossom Trl, Suite 210, Kissimmee, FL 34744 Phone: 407-933-2500 Fax: 407-933-0586 | |
Richard Ian Silver, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 591 Oak Commons Blvd, Kissimmee, FL 34741 Phone: 407-943-7100 Fax: 407-943-7328 | |
Dr. Shady Saikali, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 380 Celebration Pl Ste 401, Kissimmee, FL 34747 Phone: 407-303-4673 | |
John J Mcgetrick Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 810 N Rose Ave, Kissimmee, FL 34741 Phone: 407-943-7100 Fax: 407-943-7328 |